# A Proof of Concept Clinical Trial Evaluating the Safety and Efficacy of Eucrisa (Crisaborole) in Patients With Seborrheic Dermatitis

> **NCT03567980** · PHASE4 · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 30 (actual)

## Conditions studied

- Seborrheic Dermatitis

## Interventions

- **DRUG:** Crisaborole

## Key facts

- **NCT ID:** NCT03567980
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-01
- **Primary completion:** 2020-04-30
- **Final completion:** 2021-05-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03567980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03567980, "A Proof of Concept Clinical Trial Evaluating the Safety and Efficacy of Eucrisa (Crisaborole) in Patients With Seborrheic Dermatitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03567980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*